Clinical trial
Phase I/II Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against Tuberculosis in Pre-Adolescents Living With and Without HIV in South Africa
NCT05539989 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Randomized, Placebo-Controlled Study of the Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against Tuberculosis in Pre-Adolescents Living With and Without HIV in South Africa
- Lead sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 31, 2026
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.